Dear Global Risk Community member,
Now in 2023 as ESG has transitioned from a value-adding business function to a strategic imperative for companies, it is time to take drastic action to integrate your sustainability and business strategy, adhere to evolving global regulations and position your life sciences organization for future success.
I am therefore delighted to announce that the brand-new program for the 2nd Annual ESG in Life Science Summit launching today and this year’s event will be taking place November 13-15 in Boston!
Register now and access the answers to your most pressing ESG and sustainability challenges whether you are a small biotech company early on in your ESG journey or a large pharmaceutical organization seeking to advance an industry-leading ESG strategy including:
-
A full two-day agenda featuring 16 case studies on how future-focused life sciences organizations are establishing effective ESG functions and advancing sustainable business development to balance profitability with environmental, ethical, and legal responsibility
-
A Pre-Conference Focus Day on Transforming Life Sciences Supply Chain Sustainability designed to equip you with all the tools you need to advance your sustainable procurement, supplier diversity, supplier engagement practices and, crucially, tackle how to capture your scope 3 emissions
-
A Breakfast Deep Dive for biopharma organizations in the early stages of their ESG uncover concrete recommendations on the best way to get your entire organization onboard with ESG, advance your sustainability agenda and overcome resistance to establish an ESG function
View the Full Event Guide to see full details of the case studies and hear from this year’s speaker faculty, which includes some of the most innovative life sciences organizations leading the way in this space such as Bayer, Twist Bioscience, Sanofi, Merck, Natera, Biogen, Takeda, Thermo Fisher Scientific and more.
Don’t miss this unique chance to network with forward-thinking ESG, EHS, sustainability, CSR leaders as well as other key stakeholders in biopharma. Uncover how to embed and advance ESG and sustainability across your biopharma business (including tackling industry-specific challenges such as health equity) now to satisfy future employees, customers, and investors.
For more information, download your copy of the Full Event Guide.
We hope to see you in Boston in November!
Comments